Incorporating Fecal Calprotectin in Clinical Practice for Patients with Moderate to Severely Active Ulcerative Colitis Treated with Biologics or Small Molecule Inhibitors

BACKGROUND: We applied the GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework to evaluate the performance of fecal calprotectin (FC) as an alternative to endoscopy in patients with moderate-severe ulcerative colitis (UC) treated with a biologic agent or tofacitinib....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Gastroenterol
Hlavní autoři: Dulai, Parambir S., Battat, Robert, Barsky, Maria, Nguyen, Nghia H., Ma, Christopher, Narula, Neeraj, Mosli, Mahmoud, Casteele, Niels Vande, Boland, Brigid S., Prokop, Larry, Murad, M. Hassan, D’Haens, Geert, Feagan, Brian G., Sandborn, William J., Jairath, Vipul, Singh, Siddharth
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274901/
https://ncbi.nlm.nih.gov/pubmed/32384283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000596
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky